CHARLES F LEVENBACK to Breast Neoplasms
This is a "connection" page, showing publications CHARLES F LEVENBACK has written about Breast Neoplasms.
Connection Strength
0.062
-
The NSABP trials. N Engl J Med. 1994 Sep 22; 331(12):809.
Score: 0.022
-
. . . and how the decisions are made. N Engl J Med. 1994 Aug 04; 331(5):331; author reply 332.
Score: 0.021
-
Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res. 2012 Oct 15; 18(20):5796-805.
Score: 0.019